A powerful weapon in the battle to avoid the possibility of severe coronavirus infection and inpatient care is the pharmaceutical Molnupiravir 200mg which from Monday, January 17, 2022, is prescribed through the GHS in cases with mild to mild symptoms of the disease in the adult population. According to Health Minister Michael Hadjipandela, Cyprus is one of the first countries in the EU that has proceeded with the purchase and distribution of this important drug to its citizens.
Presenting the profile of the pharmaceutical formulation, the Deputy Director of Pharmaceutical Services, Elena Panagiotopoulou said that it is indicated for people over 65 years of age and not under 18 and can be administered to special categories of vulnerable groups of the population.
(CNA)
CNA - Argyro Angelidou
Contents of this article including associated images are owned by CNA
Views & opinions expressed are those of the author and/or CNA
Source
